Electromed, Inc. announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C. The study’s findings reveal that early use of high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduced severe exacerbations and hospitalizations among non-cystic […]
Respiratory
More than 40 percent of Women with Asthma May Develop COPD, but Risk May Be Reduced
More than 4 in 10 women with asthma may go on to develop chronic obstructive pulmonary disease (COPD), according to a study conducted in Ontario, Canada, and published online in the Annals of the American Thoracic Society. In “Asthma and COPD Overlap in Women: Incidence and Risk Factors,” Teresa To, […]
Cannabis Does Not Improve Breathlessness During Exercise in Patients With Advanced COPD
Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial published online in the Annals of the American Thoracic Society. In “Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise […]
Tobacco Regulation Advocates Get Support from Medical Professional Organizations in Court Filing
The American Thoracic Society led 10 medical professional organizations in filing an amicus brief last week regarding the FDA’s failure to apply pre-market review to new tobacco products. The brief was submitted in support of the American Academy of Pediatrics and its co-plaintiffs and outlines the compelling data indicating that the FDA’s failure to act […]
Higher Doses of Rifampin Appear More Effective in Fighting TB Without Increasing Risk of Adverse Events
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Efficacy […]
CDC Survey Results Show End to Decline in Youth E-Cigarette Use, Highlighting Urgent Need for FDA Action
Statement of American Lung Association National President and CEO Harold P. Wimmer in response to the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report “Tobacco Product Use Among Middle and High School Students—United States, 2011–2017,” released on June 6, 2018. “For the fourth straight year, the […]
Respiratory Societies Warn About E-Cigarette Use in Youth; World No Tobacco Day – May 31, 2018
Tobacco is the leading underlying single cause of death worldwide. In 2016, tobacco use caused over 7.1 million deaths mostly related to lung and heart disease, cancer, and stroke. Every year, on May 31, people and organizations mark World No Tobacco Day, by highlighting the health and other risks associated with […]
Vertex Awards $400,000 in Scholarships to CF Patients and Their Immediate Family Members
All in for CF Scholarship Program Doubles to Help 80 Recipients Pursue Higher Education Vertex Pharmaceuticals Incorporated announced the recipients of scholarships as part of its second All in for CF Scholarship program. Each of the 80 scholarship recipients will be awarded $5,000 for the 2018-2019 academic year. The Vertex […]
Study Says: Bronchiectasis Exacerbations Significantly Reduced with HFCWO Therapy
Electromed, Inc. recently announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique. The longitudinal study shows that high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related exacerbations including the need for antibiotics, emergency department visits, and […]
Driving Value With Home NIV: Discover How You Could Save Your Organization Millions
You may already know the clinical benefits of home NIV, but now discover the significant cost savings this new approach could bring to your organization. Emerging evidence has reinforced the use of home-based noninvasive ventilation (NIV) to treat patients with chronic hypercapnic COPD. This new methodology was proven in the […]













